UPC_APP_39459/2024

ANALYTE SENSOR

Procedural & sub-applicationsOther ProceduralDusseldorf LDGeneric application—Settled at: During trial

Overview Decisions Citations Documents Timeline

Parties

Claimants

Abbott Diabetes Care Inc.(Abbott Group)

Reps: Roland Küppers (Taylor Wessing); Alexander Rubusch (Taylor Wessing)

Respondents

Sibio Technology Limited
Umedwings Netherlands B.V.

Reps: Thomas Gniadek (Simmons & Simmons)

Judges

ThomasPresiding Judge
ThomLegally Qualified Judge
BessaudLegally Qualified Judge
FulconisTechnically Qualified Judge

Patents

EP 2 393 417

CPC codes: A61B5/14865, A61B2560/0475, A61B5/72, A61B5/6898, H04L67/12, A61M2205/33, C12Q1/001, A61B2560/0487, A61B5/14503, A61B5/6849, A61M5/158, A61B5/0004…

Sector: Biotechnology

Outcome

Settled

Filed: —

First decided: Jul 3, 2024

Language: —

Settled at: During trial — settled commercially

Order by Düsseldorf Local Division (UPC_CFI_133/2024, 3 July 2024) confirming settlement between Abbott Diabetes Care Inc. and Sibio/Umedwings under R. 365.1(2) RoP in provisional measures proceedings over EP 2 393 417. A 20% reimbursement of court fees was ordered, the settlement having been reached at the oral hearing stage.